Syngene is poised for strong, robust growth: Kiran Mazumdar Shaw

Time is right for Syngene IPO as it is poised for strong, robust growth says Kiran Mazumdar Shaw, CMD, Biocon.
Share this Video
appinstlBnr
Open in App
Success
This article has been saved